116574-15-3 Usage
Explanation
The molecular formula represents the number of atoms of each element present in a molecule of the compound.
Explanation
Azetidines are a class of organic compounds that contain a four-membered ring with three carbon atoms and one nitrogen atom.
Explanation
The compound is a solid at room temperature and appears white in color.
Explanation
The compound is frequently utilized in research and development processes, likely due to its unique structure and potential pharmacological activities.
Explanation
The compound has been investigated for its possible applications in medicine, particularly in the development of new drugs.
Explanation
The compound's structure features a bis-(4-fluoro-phenyl)-methyl group connected to an azetidin-3-ol ring, which may contribute to its diverse range of potential applications.
Explanation
While the compound has shown promise in certain areas, more research is required to comprehensively understand its properties, potential benefits, and possible applications.
Class
Azetidines
Physical state
White solid
Research and development
Commonly used
Potential pharmacological activities
Studied in the field of medicinal chemistry
Unique structure
Bis-(4-fluoro-phenyl)-methyl group attached to an azetidin-3-ol ring
Further research needed
To fully understand properties and uses
Check Digit Verification of cas no
The CAS Registry Mumber 116574-15-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,6,5,7 and 4 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 116574-15:
(8*1)+(7*1)+(6*6)+(5*5)+(4*7)+(3*4)+(2*1)+(1*5)=123
123 % 10 = 3
So 116574-15-3 is a valid CAS Registry Number.
116574-15-3Relevant academic research and scientific papers
Kobayashi,Inoue,Nishino,Fujihara,Oizumi,Kimura
, p. 797 - 817 (1995)
Novel 2-amino-1,4-dihydropyridine derivatives I, which contain N,N-dialkylaminoalkoxycarbonyl groups at the 3- and/or 5-position, were synthesized and their antihypertensive effects were evaluated in spontaneously hypertensive rats. Remarkably prolonged duration of antihypertensive action was observed when a tertiary amino group was introduced into either the 3- or 5-ester side-chain of the 1,4-dihydropyridine ring. In particular, the compounds containing cyclic amino moieties at the 3-position showed greater potency than those with acyclic amino moieties. Chemical modification studies indicated that the two ester side-chains of 1,4-dihydropyridine at the 3- and 5-position might function in a different manner in relation to the antihypertensive activities. 3-(1-Benzhydrylazetidin-3-yl) 5-isopropyl 2-amino-1,4-dihydro-6-methyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxyl ate, I-43 (CS-905), exhibited potent and long-lasting antihypertensive effects with gradual onset of action, and is a promising candidate as an antihypertensive drug.
